Micro Emerging Active

Designazione Fast Track della FDA di Climb Bio

Nuova narrativa con copertura limitata — ancora in formazione.

Punteggio
0,2
Velocità
▲ 0,0
Articoli
3
Fonti
1

Cronologia del Sentiment

Cronologia degli Eventi

Mag 05, 2026
Climb Bio (CLYM) Enters Agreement for $110M Private Placement Financing Bullish
Apr 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
Apr 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

Articoli Correlati

Climb Bio (CLYM) Enters Agreement for $110M Private Placement Financing

Yahoo Finance · Mag 05, 2026
Bearish

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · Apr 24, 2026
Mixed

Cronologia

Ultimo aggiornamentoApr 22, 2026